Cleveland Biolabs Inc (NASDAQ:CBLI)

3.38
Delayed Data
As of Feb 27
 +0.09 / +2.74%
Today’s Change
3.07
Today|||52-Week Range
17.46
-40.70%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues8.8M3.6M8.5M3.7M
 
 
 
 
 
Depreciation And Amortization525.5K479.6K471.2K--
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses33.4M33.1M30.6M18.1M
 
 
 
 
 
Research And Development22.8M22.5M19.0M9.7M
 
 
 
 
 
Total Operating Expenses33.9M33.6M31.1M18.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.1M-30.0M-22.6M-14.4M
 
 
 
 
 
Extraordinary Credit19.8M7.7M2.9M2.7M
 
 
 
 
 
Extraordinary Charge0.000.00-506.2K--
 
 
Pre-Tax Equity Earnings0.00407.4K217.3K-285.5K
 
 
 
 
Interest Expense On Debt0.00477.4K134.2K1.1M
 
 
 
 
Other Expenses-130.0K0.000.0013.2M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.2M-22.4M-20.1M35.4K
 
 
 
 
 
Minority Interest-1.2M-4.2M-2.9M-1.6M
 
 
 
 
 
Net Income-4.0M-18.2M-17.3M1.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.6M1.9M2.3M2.7M
 
 
 
 
 
Shares To Calculate EPS Diluted1.6M1.9M2.3M2.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.40-$9.80-$7.60$12.00
 
 
 
 
 
EPS Diluted-$2.40-$9.80-$7.60$0.60
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account